Fig. 1: Overview of the treatment schedule and characteristics of an advanced-stage high-grade serous fallopian tube carcinoma.

a Neoadjuvant chemotherapy treatment and sample acquisition for scRNA-seq. b CT imaging showing the clinical responses to NACT of the patient with high-grade serous fallopian tube carcinoma. c H&E staining of the pre-NACT and post-NACT samples. d IHC staining of PAX8, Ber-EP4, CA125, Ki-67, and p16 protein in pre-NACT and post-NACT tissue samples of the high-grade serous fallopian tube carcinoma.